CONMED Corporation (CNMD): Price and Financial Metrics

CONMED Corporation (CNMD)

Today's Latest Price: $74.62 USD

0.68 (0.92%)

Updated Jun 2 6:40pm

Add CNMD to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

CNMD Stock Summary

  • CNMD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 214.84 -- higher than 84.57% of US-listed equities with positive expected earnings growth.
  • Conmed Corp's stock had its IPO on March 26, 1990, making it an older stock than 83.88% of US equities in our set.
  • With a price/earnings ratio of 63.5, Conmed Corp P/E ratio is greater than that of about 89.78% of stocks in our set with positive earnings.
  • Stocks that are quantitatively similar to CNMD, based on their financial statements, market capitalization, and price volatility, are GCP, LNN, CMD, EML, and NVT.
  • CNMD's SEC filings can be seen here. And to visit Conmed Corp's official web site, go to
CNMD Daily Price Range
CNMD 52-Week Price Range

CNMD Stock Price Chart More Charts

CNMD Price/Volume Stats

Current price $74.62 52-week high $116.81
Prev. close $73.94 52-week low $37.66
Day low $73.73 Volume 211,300
Day high $74.98 Avg. volume 454,649
50-day MA $65.86 Dividend yield 1.07%
200-day MA $92.67 Market Cap 2.13B

CONMED Corporation (CNMD) Company Bio

CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company was founded in 1970 and is based in Utica, New York.

CNMD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

We started the process of determining a valid price forecast for Conmed Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Conmed Corp ranked in the 26th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for CNMD, they are:

  • Conmed Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than 61.81% of tickers in our DCF set.
  • CNMD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 7%; for context, that number is higher than 61.81% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), Conmed Corp has a reliance on debt greater than 72.84% of them.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CNMD, try ABT, NUVA, ENTA, TMO, and BHC.

CNMD Latest News Stream

Event/TimeNews Detail
Loading, please wait...

CNMD Latest Social Stream

Loading social stream, please wait...

View Full CNMD Social Stream

Latest CNMD News From Around the Web

Below are the latest news stories about Conmed Corp that investors may wish to consider to help them evaluate CNMD as an investment opportunity.

Here's Why You Should Retain CONMED (CNMD) Stock for Now

CONMED (CNMD) continues to benefit from broad product portfolio and persistent focus on R&D. However, forex remains a woe.

Zacks Investment Research | May 27, 2020

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 6, 2020 to all shareholders of record as of June 15, 2020.

Yahoo | May 21, 2020

Edited Transcript of CNMD earnings conference call or presentation 29-Apr-20 8:30pm GMT

Q1 2020 Conmed Corp Earnings Call

Yahoo | May 18, 2020

CONMED Corporation Announces That 2020 Annual Meeting of Shareholders Will Be Virtual-Only Meeting Due to COVID-19

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its 2020 Annual Meeting of Shareholders, scheduled for May 21, 2020, at 1:30 p.m. ET, will be hosted as a virtual-only meeting due to public health concerns and social-distancing restrictions imposed by governmental authorities with respect to non-essential gatherings arising from the COVID-19 pandemic. Information about the virtual meeting webcast and instructions for how shareholders can participate in the Annu

Business Wire | May 11, 2020

Outlook into the Worldwide Electrosurgery Devices Industry to 2025 - Featuring Johnson & Johnson, Conmed & Stryker Among Others -

DUBLIN--(BUSINESS WIRE)--The "Global Electrosurgery Devices Market By Product (Electrosurgical Generators, Electrosurgical Instruments, Accessories), By Application, By End-user, By Region, Forecast & Opportunities, 2025" report has been added to's offering. The Global Electrosurgery Devices Market is expected to grow at a steady rate during the forecast period. Growing trend of plastic surgeries, initiated by the celebrities to look younger has influenced a large par

Business Wire | May 7, 2020

Read More 'CNMD' Stories Here

CNMD Price Returns

1-mo 9.77%
3-mo -21.35%
6-mo -34.24%
1-year -7.94%
3-year 47.83%
5-year 42.84%
YTD -33.08%
2019 75.71%
2018 27.39%
2017 17.33%
2016 2.19%
2015 -0.42%

CNMD Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full CNMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9604 seconds.